Clinical implications of splenium magnetic resonance imaging signal changes

Archives of Neurology

Volumn 62, Issue 3, 2005, Pages 433-437

  Doherty, Michael J ^a,c   Jayadev, Sumie ^a   Watson, Nathaniel F ^a   Konchada, Ravi S ^b   Hallam, Dan K ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Epilepsy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CYCLOSPORIN; FLUOROURACIL; LITHIUM; THIAMINE;

ALCOHOL CONSUMPTION; ARTICLE; ATAXIA; BRAIN DISEASE; BRAIN INJURY; BRAIN REGION; CLINICAL FEATURE; CONFUSION; DEATH; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; ELECTROLYTE DISTURBANCE; HUMAN; HYPERNATREMIA; HYPOGLYCEMIA; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SPLENIUM;

ADOLESCENT; ADULT; ATAXIA; CONFUSION; CORPUS CALLOSUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; SYNDROME;

EID: 14844286146     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.3.433     Document Type: Article

References (50)

1. Kawamura M, Shiota J, Yagishita T, Hirayama K. Marchiafava-Bignami disease: computed tomographic scan and magnetic resonance imaging. Ann Neurol. 1985;18:103-104.
2. Delangre T, Mannequin D, Clavier E, et al. Marchiafava-Bignami disease with favorable development [in French]. Rev Neurol. 1986;142:933-936.
3. Inagaki T, Saito K. A case of Marchiafava-Bignami disease demonstrated by MR diffusion-weighted image [in Japanese]. No To Shinkei. 2000;52:633-637.
4. Gass A, Birtsch G, Olster M, Schwartz A, Hennerici MG. Marchiafava-Bignami disease: reversibility of neuroimaging abnormality. J Comput Assist Tomogr. 1998;22:503-504.
5. Ruiz-Martinez J, Martinez Perez-Balsa A, Ruibal M, et al. Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology. 1999;41:40-43.
6. Chang KH, Cha SH, Han MH, et al. Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology. 1992;34:480-482.
7. Gambini A, Falini A, Moiola L, et al. Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. AJNR Am J Neuroradiol. 2003;24:249-253.
8. Hayashi T, Tanohata K, Kunimoto M, Inoue K. Marchiafava-Bignami disease with resolving symmetrical putaminal lesion. J Neurol. 2002;249:227-228.
9. Celik Y, Kaya M, Sengun S, Utku U. Marchiafava-Bignami disease: cranial MRI and SPECT findings. Clin Neurol Neurosurg. 2002;104:339-341.
10. Helenius J, Tatlisumak T, Soinne L, Valanne L, Kaste M. Marchiafava-Bignami disease: two cases with favourable outcome. Eur J Neurol. 2001;8:269-272.
11. Yamamoto T, Ashikaga R, Araki Y, Nishimura Y. A case of Marchiafava-Bignami disease: MRI findings on spin-echo and fluid attenuated inversion recovery (FLAIR) images. Eur J Radiol. 2000;34:141-143.
12. Baron R, Heuser K, Marioth G. Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures. J Neurol. 1989;236:364-366.
13. Caparros-Lefebvre D, Pruvo JP, Josien E, et al. Marchiafava-Bignami disease: use of contrast media in CT and MRI. Neuroradiology. 1994;36:509-511.
14. Pasutharnchat N, Phanthumchinda K. Marchiafava-Bignami disease: a case report. J Med Assoc Thai. 2002;85:742-746.
15. Takayama H, Kobayashi M, Sugishita M, Mihara B. Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg. 2000;102:135-139.
16. Mendelsohn DB, Levin HS, Harward H, Bruce D. Corpus callosum lesions after closed head injury in children: MRI, clinical features and outcome. Neuroradiology. 1992;34:384-388.
17. Kato Z, Kozawa R, Hashimoto K, Kondo N. Transient lesion in the splenium of the corpus callosum in acute cerebellitis. J Child Neurol. 2003;18:291-292.
18. Cordoliani YS, Sarrazin JL, Felten D, et al. MR of cerebral malaria. AJNR Am J Neuroradiol. 1998;19:871-874.
19. Kobata R, Tsukahara H, Nakai A, et al. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy. J Comput Assist Tomogr. 2002;26:825-828.
20. Mito Y, Yoshida K, Kikuchi S. Measles encephalitis with peculiar MRI findings: a report of two adult cases. Neurol Med. 2002;56:251-256.
21. Kobuchi N, Tsukahara H, Kawamura Y, et al. Reversible diffusion-weighted MR findings of Salmonella enteritidis-associated encephalopathy. Eur Neurol. 2003;49:182-184.
22. Ogura H, Takaoka M, Kishi M, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol. 1998;19:1144-1145.
23. Signorini E, Lucchi S, Mastrangelo M, et al. Central nervous system involvement in a child with hemolytic uremic syndrome. Pediatr Nephrol. 2000;14:990-992.
24. Kieburtz KD, Ketonen L, Zettelmaier AE, et al. Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol. 1990;47:643-645.
25. Ochi H, Yamashita Y. A case of adult type adrenoleukodystrophy with an acute onset and repeated episodes of ataxic dysarthria [in Japanese]. Rinsho Shinkeigaku. 1996;36:1229-1233.
26. Oster J, Doherty C, Grant PE, et al. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia. 2003;44:852-854.
27. Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology. 2003;60:1838-1841.
28. Wong SH, Turner N, Birchall D, et al. Reversible abnormalities of DWI in high-altitude cerebral edema. Neurology. 2004;62:335-336.
29. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients. AJNR Am J Neuroradiol. 1999;20:125-129.
30. Cohen-Gadol AA, Britton JW, Jack CR Jr, Friedman JA, Marsh WR. Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. J Neurosurg. 2002;97:714-717.
31. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases. J Neurol Neurosurg Psychiatry. 2001;70:459-463.
32. Gimeno MJ, Lasierra R, Pina JI. Marchiafava Bignami disease: four case reports Rev Neurol. 2002;35:596-598.
33. Hackett PH, Yarnell PR, Hill R, et al. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA. 1998;280:1920-1925.
34. Johnson M, Maciunas R, Dutt P, et al. Granulomatous angiitis masquerading as a mass lesion: magnetic resonance imaging and stereotactic biopsy findings in a patient with occult Hodgkin's disease. Surg Neurol. 1989;31:49-53.
35. Pekala JS, Mamourian AC, Wishart HA, et al. Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy. AJNR Am J Neuroradiol. 2003;24:855-861.
36. Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand. 2002;106:379-386.
37. Miyake K, Kamimura T, Gondo H, Okamura T, Niho Y. Tacrolimus administration to a patient with cyclosporine-induced encephalopathy after allogeneic bone marrow transplantation [in Japanese]. Rinsho Ketsueki. 2000;41:585-590.
38. Epstein MA, Zimmerman RA, Rorke LB, Sladky JT. Late-onset globoid cell leukodystrophy mimicking an infiltrating glioma. Pediatr Radiol. 1991;21:131-132.
39. Suwanwela MC, Leelacheavasit N. Isolated corpus callosal infarction secondary to pericallosal artery disease presenting as alien hand syndrome. J Neurol Neurosurg Psychiatry. 2002;72:533-536.
40. Kollar J, Peter M, Fulesdi B, Sikula J. Is every sharply defined, symmetrical, necrotic-demyelinating lesion in the corpus callosum an actual manifestation of Marchiafava-Bignami disease? Eur J Radiol. 2001;39:151-154.
41. Ito T, Sakai T, Inagawa S, Utsu M, Bun T. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol. 1995;16:1344-1346.
42. Marchiafava B, Bignami A. Sopra una alterazione del corpo calloso osservata in suggetti alcoolistis. Riv Pat Med. 1903;8:544-599.
43. Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology. 2001;221:43-50.
44. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217:331-345.
45. Whittali KP, MacKay AL, Graeb DA, et al. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med. 1997;37:34-43.
46. Rosenthal R, Bigelow LB. Quantitative brain measurements in chronic schizophrenia. Br J Psychiatry. 1972;121:259-264.
47. Casanova MF, Zito M, Bigelow LB, et al. Axonal counts of the corpus callosum of schizophrenic patients. J Neuropsychiatry Clin Neurosci. 1989;1:391-393.
48. Masrallah HA, McCalley-Whitters M, Bigelow LB, et al. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res. 1983;8:251-260.
49. Keshavan MS, Diwadkar VA, Harenski K, Rosenberg DR, Sweeney JA, Pettegrew JW. Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. J Neurol Neurosurg Psychiatry. 2002;72:757-760.
50. Motomura M, Satani S, Inaba M. Monozygotic twin cases of the agenesis of the corpus callosum with schizophrenic disorder. Psychiatry Clin Neurosci. 2002;56:199-202.